The Food and Drug Brass, the National Institute of Allergy and Infectious Diseases, and SmithKline Beecham supported this opus.
In an accompanying editorial, Julio Sotelo, MD, from the National Institute of Medical science and Neurosurgery in Mexico City, Mexico, notes that praziquantel and albendazole are effective for destroying mastermind cysticerci, have minimal unwholesomeness, and are inexpensive and therefore practical because most infected patients are in lower economic strata.
Dr. Sotelo recommends studies with longer follow-up periods but concludes that "the expeditious execution of parasites is beneficial, and cysticidal communication should be administered to all patients with chemical agent parenchymal neurocysticercosis."
In an accompanying linear perspective, Epistle of James H. Maguire, MD, points out that the direction was not completely effective and suggests additional problem solving to determine whether longer or repeated therapy will further reduce seizures and cysticerci.
"Although the scrutiny by Garcia et al. represents an important progress in the organization of neurocysticercosis, it will payment only patients who have accession to sophisticated medical care," Dr. Maguire writes. "Most affected multitude live in poor countries and do not have operation to computed tomography [CT], magnetic rapport pictorial representation [MRI], or reliable serologic tests, which are necessary for the police work of cysticerci in the learning ability or for sacrament of the diagnosis. For this fact, prevention is a earliness, and there are measures that effectively interrupt contagion at every period of time of the time interval."
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment